CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing

Go back to CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing
(NASDAQ: CDNA) Delayed: 25.06 +0.01 (0.04%)
Previous Close $25.05    52 Week High $6.87 
Open $24.70    52 Week Low $3.28 
Day High $25.65    P/E N/A 
Day Low $24.50    EPS $0.00 
Volume 163,637